Cipla forms JV with Jiangsu Acebright for respiratory medicines in China

The agreement is between Chinese firm Jiangsu Acebright and Cipla's European arm, Cipla EU for a combined investment of USD 30 million, as per a company statement.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news